Skip to main content
. 2015 Jun 2;2015(6):CD011438. doi: 10.1002/14651858.CD011438.pub2

1.8. Analysis.

1.8

Comparison 1 Long‐acting muscarinic antagonists (LAMA) add‐on versus long‐acting beta2‐agonists (LABA) add‐on, Outcome 8 Trough forced vital capacity (FVC) (L).